Tag: AbbVie Inc
-

A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled
Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.
-

I just bought this pharma stock for its next generation of blockbuster drugs — and its dividend
AbbVie is entering a new chapter of growth, fueled by its blockbuster immunology drugs and expanding neuroscience business. Investor Kevin Simpson shares why he’s optimistic.
-

Anything not tied to artificial intelligence took off this week
S&P 500 stocks beyond the realm of AI are on pace for their second-largest weekly outperformance since 2024.
-

J&J’s 6% slide on an imperfect quarter is a gift to prospective buyers
J&J’s pharmaceutical division is humming along, and the MedTech problems should be temporary.
-

There’s one pharma-linked stock most investors have never heard of. It’s on Josh Brown’s list
If you’ve ever gotten a vaccine, this company was likely part of how that drug reached you, says Josh Brown.
-

Biotech stocks are breaking out. How Josh Brown is trading them
Josh Brown and Sean Russo take a look at these two biotech names after a strong week for the sector.
-

Two biotech names on Josh Brown’s Best Stocks list are making meaningful highs this summer
Josh Brown and Sean Russo break down these two stocks on their list.
-

Great British sell-off? UK takeovers accelerate in a big way
Last week, three British companies accepted takeover bids on the same day. It’s a growing trend, but can the U.K. really afford to let such companies go?
-

What to know about testosterone replacement therapy as the U.S. military plans to test troops
While some research has shown benefits for patients who qualify, questions remain about the therapy’s long-term risks and use among men without a medical need.
-

The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly’s acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma’s embrace of a stigmatized class of medications for treating mental health.
Latest News

Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany india Investment strategy iran Iran war markets People per politics return russia S&P 500 Index said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World World Cup 2026
About the Author

AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.

Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed












